Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950120-07-000519
Filing Date
2007-09-18
Accepted
2007-09-18 19:14:53
Documents
1
Period of Report
2007-08-17

Document Format Files

Seq Description Document Type Size
1 twegman-bioform4_0918ex.html 4  
1 twegman-bioform4_0918ex.xml 4 4985
  Complete submission text file 0000950120-07-000519.txt   6728
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1764 BRIAR PLACE MERRICK NY 11566
Business Address 516 593 7000
Wegman Thomas (Reporting) CIK: 0001355189 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19879 | Film No.: 071123358